Skip to main content
European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS
CORDIS Web 30th anniversary CORDIS Web 30th anniversary

Innovative biocompatible game changing material for medical implants in trauma

Objetivo

MMATECH was founded in 2001 to address the challenge of developing better biomaterials for medical devices in orthopaedics. We developed a new engineering modified wear-free biopolymer (MP-1™) for medical devices: dental implants and acetabular liner for hip replacement implants, proved in clinical trials and granted with CE mark. Within MP-ORIF project we will introduce to the market a new game changing Open Reduction Internal Fixation (ORIF) implant made of MP-1TM, called MP-ORIF. This new polyimide polymer will substitute the currently metal orthopaedic implants used in trauma surgery. Orthopaedic fractures are a common acute health issue. A significant increase of bone fractures is foreseen in the coming years due to population aging, more active lifestyle and traffic accidents. All standard metal internal fixator nails have predrilled holes which require a special trained doctor to locate them in the body under Xray to insert the fixation screws. In MP-ORIF the drilling will be produced in the body enabling a robust design without holes, eliminating repeated X-ray imaging which is costly and potentially dangerous. The nail can stay in the body for life-time with no pain caused by outer temperature change. We therefore predict that MP-ORIF will become the gold standard for directly-insert bone fixation in trauma. MP-ORIF will have a significant impact on various levels: (i) market/clients (hospitals, healthcare, doctors): shorter surgery time, higher success rate and an over 50 % lower cost; (ii) end-user (patients): shorter post-operation recovery, greatly reduced scarring; (iii) company: increase in MMATECH’s revenue; (iv) stakeholders: lower public healthcare costs; (v) society: developing economies may gain access to high quality trauma care otherwise impossible. Women will be the major beneficiaries from MP-ORIF project since approximately 80% of the world populations affected by osteoporosis, osteoarthritis and bone injuries are women over 50.

Convocatoria de propuestas

H2020-SMEInst-2016-2017

Consulte otros proyectos de esta convocatoria

Convocatoria de subcontratación

H2020-SMEINST-2-2016-2017

Régimen de financiación

SME-2 - SME instrument phase 2

Coordinador

M.M.A. TECH LTD
Aportación neta de la UEn
€ 1 161 785,10
Dirección
HAGAATON AVE 1
2201202 Naharia
Israel

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
€ 1 659 693,00